2025 Regular Session • New Hampshire Legislature
HB645
Legislative Summary
Relative to data collection and reporting requirements of the prescription drug affordability board.
Demographic Impact
Overall analysis of equity impact
70% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/21/2025
Introduced (in recess of) 01/09/2025 and referred to Health, Human Services and Elderly Affairs House Journal 3 P. 21
House of Representatives
1/29/2025
Public Hearing: 02/05/2025 11:30 am Legislative Office Building 210-211
House of Representatives
3/3/2025
Executive Session: 02/05/2025 11:30 am Legislative Office Building 210-211
House of Representatives
3/3/2025
Committee Report: Ought to Pass with Amendment # 2025-0505h 02/19/2025 (Vote 17-0; Regular Calendar)
House of Representatives
3/13/2025
Lay HB 645 on Table (Rep. Osborne): Motion Adopted Voice Vote 03/13/2025 House Journal 8 P. 78
House of Representatives
Status Information
Current Status
Introduced(1/21/2025)
Chamber
House of Representatives
Sponsors
Republican: 2
Democrat: 2
Primary Sponsor
Jess Edwards
Republican